CDER Drug Safety Labeling Changes - 3/30/2021

Drug Safety-related Labeling Changes (SrLC) The SLC database has been updated with the following approved drug safety labeling changes. Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated OZEMPIC SEMAGLUTIDE 209637 NDA 03/28/2022 03/30/2022 TYKERB LAPATINIB DITOSYLATE 022059 NDA 03/27/2022 03/30/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA